Paola Melotti
Verona, 37126, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 63 publications
Differential Evolution of Achromobacter spp. Isolates in Upper and Lower Airways of People with Cystic Fibrosis.
Journal: Pathogens (Basel, Switzerland)
Published: March 31, 2026
Real-life application of the Optical Beta-Adrenergic Sweat Test for people with cystic fibrosis.
Journal: Pulmonary pharmacology & therapeutics
Published: March 03, 2026
CFTR Modulator Response in Nasal Organoids Derived from People with Cystic Fibrosis.
Journal: Cells
Published: October 02, 2025
Comparison of preclinical drug efficacy in nasal and intestinal patient-derived models of cystic fibrosis.
Journal: European journal of pharmacology
Published: September 04, 2025
Corrigendum to "Evaluation of the response to elexacaftor-tezacaftor-ivacaftor of the rare CFTR variants L383S, I507del, L1065P and R1066H in intestinal organoid-derived epithelial monolayers" [Journal of Cystic Fibrosis xxx (2025) 1-10].
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: March 01, 2025
Development of a Simple and Accurate Molecular Protocol Using 16SrRNA for Species-Specific Identification of Achromobacter spp.
Journal: Pathogens (Basel, Switzerland)
Published: January 24, 2025
Real-Life Experience with CFTR Modulators Shows Correction of LAD-IV Phenotype in Cystic Fibrosis.
Journal: American journal of respiratory cell and molecular biology
Published: October 01, 2024
Reply to: Cystic fibrosis transmembrane conductance regulator (CFTR) variants and CFTR function in patients with pancreatitis.
Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
Published: July 25, 2024
Adenine base editing with engineered virus-like particles rescues the CFTR mutation G542X in patient-derived intestinal organoids.
Journal: iScience
Published: June 11, 2024
Evaluation of the response to elexacaftor-tezacaftor-ivacaftor of the rare CFTR variants L383S, I507del, L1065P and R1066H in intestinal organoid-derived epithelial monolayers.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: June 01, 2024
Elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis and rare mutations.
Journal: Pediatric pulmonology
Published: April 15, 2024
Last Updated: 09/26/2026